Enigma Diagnostics, the decentralised and point-of-care molecular diagnostics Company, announces that it has been awarded a grant of £1.8M from the UK Government’s Technology Strategy Board under the “Technologies for Health” programme.

The Haematology programme from Randox International Quality Assessment Scheme (RIQAS) offers quick and easy quality control analysis for eight analytes.

RanplexCRC is a diagnostic test that can detect 28 polymorphisms associated with colorectal cancer in a single stool sample. 

Alba Bioscience has been granted clearance to supply blood typing reagents into Canada, a significant move further strengthening the Company’s position on the world stage.